Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Washington University School of Medicine
BioCentury | Nov 20, 2024
Discovery & Translation
Science Spotlight: A new obesity target may avoid nausea, muscle loss
BioCentury’s roundup of translational innovation: Embark/Novo discover new obesity target, Canbridge delivers large DMD gene, and more
BioCentury | Oct 31, 2024
Discovery & Translation
Science Spotlight: Macrophage-fibroblast cross-talk in heart failure
BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
BioCentury | Aug 8, 2024
Discovery & Translation
Science Spotlight: Stopping herpes from entering neurons, tissue-specific nanoparticles, and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 12, 2024
Discovery & Translation
Distillery spotlight: new mitochondrial mechanisms from academia
Correcting mitochondrial dynamics, metabolic control of pathogenic or therapeutic cells emerge among translational innovations in BioCentury’s survey of 2023 publications
BioCentury | Feb 29, 2024
Regulation
Ultrarare inflection point: stakeholders argue for biomarker-based approvals
Reagan-Udall Foundation meeting on biomarkers could change FDA policy on neuronal MPS endpoints, unleash approvals
BioCentury | Jan 16, 2024
Regulation
Jan. 16 Quick Takes: Casgevy gains quick label expansion in β-thalassemia
Plus: Deerfield adds Washington University in St. Louis to arsenal of academic center collaborations and updates from Allakos, GSK
BioCentury | Dec 1, 2023
Discovery & Translation
CorrectSequence’s hemoglobin base editor; plus Denali’s LXR agonist and more
BioCentury’s roundup of translational innovations
BioCentury | Aug 23, 2023
Discovery & Translation
Resetting the iPS cell epigenome; plus microglia-targeted AAV and more
BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 224